Alecensa Interactions
There are 113 drugs known to interact with Alecensa (alectinib), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 9 are major, and 104 are moderate.
- View all 113 medications that may interact with Alecensa
- View Alecensa alcohol/food interactions (1)
- View Alecensa disease interactions (5)
Most frequently checked interactions
View interaction reports for Alecensa (alectinib) and the medicines listed below.
- Actemra (tocilizumab)
- Adcirca (tadalafil)
- Adempas (riociguat)
- Afinitor (everolimus)
- amiodarone
- Ampyra (dalfampridine)
- Aralast NP (alpha 1-proteinase inhibitor)
- Aranesp (darbepoetin alfa)
- atorvastatin
- Aubagio (teriflunomide)
- Avastin (bevacizumab)
- Avonex (interferon beta-1a)
- azithromycin
- benzonatate
- carvedilol
- Celexa (citalopram)
- Cosentyx (secukinumab)
- cyclobenzaprine
- Eliquis (apixaban)
- famotidine
- furosemide
- Keppra (levetiracetam)
- levothyroxine
- montelukast
- omeprazole
- ondansetron
- Vitamin D3 (cholecalciferol)
- Xalkori (crizotinib)
- Xgeva (denosumab)
- Zofran (ondansetron)
Alecensa alcohol/food interactions
There is 1 alcohol/food interaction with Alecensa (alectinib).
Alecensa disease interactions
There are 5 disease interactions with Alecensa (alectinib) which include:
Report options
QR code containing a link to this page
More about Alecensa (alectinib)
- Alecensa consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
